User profiles for Maria Saridaki
Maria SaridakiNational and Kapodistrian University of Athens Verified email at media.uoa.gr Cited by 233 |
[HTML][HTML] Swarm learning for decentralized and confidential clinical machine learning
…, C Siever, M Kraut, M Desai, B Monnet, M Saridaki… - Nature, 2021 - nature.com
Fast and reliable detection of patients with severe and heterogeneous illnesses is a major
goal of precision medicine 1 , 2 . Patients with leukaemia can be identified using machine …
goal of precision medicine 1 , 2 . Patients with leukaemia can be identified using machine …
[HTML][HTML] Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
…, M Mouktaroudi, E Karakike, M Saridaki… - The Lancet …, 2021 - thelancet.com
Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …
[HTML][HTML] Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients
…, L Bonaguro, N Reusch, K Baßler, M Saridaki… - Genome medicine, 2021 - Springer
Background The SARS-CoV-2 pandemic is currently leading to increasing numbers of
COVID-19 patients all over the world. Clinical presentations range from asymptomatic, mild …
COVID-19 patients all over the world. Clinical presentations range from asymptomatic, mild …
An open label trial of anakinra to prevent respiratory failure in COVID-19
Background: It was studied if early suPAR-guided anakinra treatment can prevent severe
respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml …
respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml …
[PDF][PDF] Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure
…, G Tsoukalas, C Selmi, C Samaras, M Saridaki… - Cell Reports …, 2022 - cell.com
Most patients infected with SARS-CoV-2 (COVID-19) experience mild, non-specific symptoms,
but many develop severe symptoms associated with an excessive inflammatory response. …
but many develop severe symptoms associated with an excessive inflammatory response. …
[HTML][HTML] Utilization of hybrid approach towards advanced database of concrete beams strengthened in shear with FRPs
TC Rousakis, ME Saridaki, SA Mavrothalassitou… - Composites Part B …, 2016 - Elsevier
This paper concerns the shear behavior of reinforced concrete beams externally strengthened
with composite materials. The study gathers numerous experiments on concrete beams, …
with composite materials. The study gathers numerous experiments on concrete beams, …
Plasmacytoid dendritic cells drive acute asthma exacerbations
AD Chairakaki, MI Saridaki, K Pyrillou… - Journal of Allergy and …, 2018 - Elsevier
Background Although acute exacerbations, mostly triggered by viruses, account for the
majority of hospitalizations in asthmatic patients, there is still very little known about the …
majority of hospitalizations in asthmatic patients, there is still very little known about the …
ESCAPE: an open-label trial of personalized immunotherapy in critically lll COVID-19 patients
…, I Koutsodimitropoulos, M Saridaki… - Journal of innate …, 2022 - karger.com
Background: Macrophage activation-like syndrome (MALS) and complex immune
dysregulation (CID) often underlie acute respiratory distress (ARDS) in COVID-19. We aimed to …
dysregulation (CID) often underlie acute respiratory distress (ARDS) in COVID-19. We aimed to …
Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome
…, OD Konsta, I Giotakis, MI Saridaki… - Clinical & …, 2016 - academic.oup.com
Type III interferons (IFNs) or IFN-λs (IFN-λ1/IL29, IFN-λ2/interleukin (IL)−28A and IFN-λ3/IL-28B)
consist of a recently identified group of IFNs, implicated initially in several human …
consist of a recently identified group of IFNs, implicated initially in several human …
[HTML][HTML] BioFire® FilmArray® Pneumonia Panel for Severe Lower Respiratory Tract Infections: Subgroup Analysis of a Randomized Clinical Trial
…, A Safarika, G Damoraki, V Lekakis, M Saridaki… - Infectious Diseases and …, 2021 - Springer
Introduction The epidemiology of severe lower respiratory tract infections (LRTI) is constantly
changing. We aimed to describe it using the BioFire ® FilmArray ® Pneumonia plus (PNplus…
changing. We aimed to describe it using the BioFire ® FilmArray ® Pneumonia plus (PNplus…